Exosome Diagnostics
Dan Baughman has extensive experience in the biotechnology and diagnostic industries, currently serving as Regional Sales Manager, Head of Marketing, and Director of Clinical Affairs/Market Development at Exosome Diagnostics since July 2014. In this role, Dan Baughman focuses on the commercialization of oncology diagnostic tests, developing communication strategies, implementing social media campaigns, and conducting market research and forecasting. Previous positions included Director of National Accounts at Precision Therapeutics from October 2010 to February 2012 and National Accounts Manager at Oncotech from April 2005 to October 2010. Dan Baughman holds a Bachelor of Science in Marketing from Wayne State University and has academic backgrounds from Divine Child and the University of Michigan-Dearborn.
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.